EOCN — EoCene Ltd.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1595353 ·
Israel
Last close
$2.46
Market Cap
$2.63M
52W High
$10.08
52W Low
$2.05
ADV30
7,772
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -2,775,000 | -2,723,000 | 18,283,000 | 2,885,000 | 5,545,000 |
| Mar 2026 | 0 | — | -2,044,000 | -1,910,000 | 16,027,000 | 1,600,000 | 2,079,000 |
| Dec 2025 | 0 | — | -3,042,000 | -4,818,000 | 18,627,000 | 3,985,000 | 2,845,000 |
| Sep 2025 | 0 | — | -2,095,000 | -1,892,000 | 21,584,000 | 3,314,000 | 2,472,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-8,543,000
Investing CF
$3,820,000
Financing CF
$2,680,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-12.88
As of
2026-09-13
Balance + Analyst (yfinance extras)
Retained Earnings
$-215,411,000
Inventory
—
Receivables
$323,000
ST Investments
$8,346,000
EBIT TTM
$-9,956,000
Pretax Income TTM
$-11,343,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -8,510,000 | -10,309,000 | 18,627,000 | 2,845,000 | 15,782,000 | -6,315,000 |
| Dec 2024 | 0 | -6,278,000 | -7,517,000 | 18,500,000 | 2,173,000 | 16,327,000 | -5,880,000 |
| Dec 2023 | 0 | -7,492,000 | -6,912,000 | 16,629,000 | 2,750,000 | 13,879,000 | -6,137,000 |
| Dec 2022 | 0 | -17,651,000 | -17,866,000 | 16,561,000 | 3,138,000 | 13,423,000 | -18,501,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MBIO | MUSTANG BIO, INC. | $2.63M | $0.39 | — |
| NXTS | Nexentis Technologies Inc. | $2.65M | $1.82 | — |
| ERNA | Ernexa Therapeutics Inc. | $2.66M | $1.63 | — |
| BIXT | BIOXYTRAN, INC | $2.66M | $0.02 | — |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $2.52M | $4.30 | — |
News headlines (Yahoo Finance, 1h cache)
Eocene and Barcode Nanotech Report Progress in the Development of Tumor Microenvironment-Targeted Lipid Nanoparticles Formulation of Aramchol
2026-11-16 13:00 · Yahoo
Eocene Announces its First European Sales and Distribution Agreement to Accelerate the Commercialization of Colospan's CG-100 Device
2026-11-10 13:00 · Yahoo
Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation
2026-09-09 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.